Congenital Adrenal Hyperplasia (CAH)

DBCOND0033416Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesEndocrine System Diseases

Congenital Adrenal Hyperplasia (CAH) is the indication for 13 drugs in DrugBank. It is covered by 14 curated, structured indications.

Also known as
Adrenal Hyperplasia, Congenital · congenital dadrenal hyperplasia · Congenital Adrenal Hyperplasia · Adrenal Hyperplasia Congenital · CAH - Congenital Adrenal Hyperplasia
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0000487ICD-10E25.0SNOMED CT190511001MedDRA10001383UMLSC0001627

What you can answer from here — as of October 03, 2026

13Indicated drugsWith each drug's targets and mechanism
Listed above
14Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
49Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Congenital Adrenal Hyperplasia (CAH) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In